Sentences with phrase «localized prostate cancer»

Pretreatment Total Testosterone Level Predicts Pathological Stage in Patient with Localized Prostate Cancer Treated with Radical Prostatectomy.

Radical treatment such as surgery and radiation for localized prostate cancer may cause significant side effects.

The study involved 1,531 men with newly diagnosed, clinically localized prostate cancer, meaning the disease hadn't spread to other parts of the body.

Whether and how to treat localized prostate cancer is thus a difficult decision, and depends largely upon an appraisal of the aggressiveness of the tumor and the likelihood that the cancer will spread to other organs.

The team looked at 555 patients with localized prostate cancer who underwent RP between 2004 and 2010.

The current authors evaluated the effects of ADT on mental and emotional well - being in men diagnosed with localized prostate cancer using data from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry, which consists of data from largely community - based practices across the United States.

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

In a report published in the New England Journal of Medicine, scientists say that a panel of 20 genes can distinguish the more common localized prostate cancer that grows slowly and rarely spreads from the more aggressive type that can spread quickly.

For localized prostate cancer the current «gold standard» treatment is Radical Prostatectomy (RP).

In the experiments reported in Nature, the scientists used mass spectrometry, a technique that identifies chemicals based on the size and electrical charge of their components, to compare the levels of 1,126 metabolites in healthy prostate tissue, clinically localized prostate cancer, and metastatic prostate cancer.

The much - awaited results of a large randomized trial comparing three approaches to localized prostate cancer were published in The New England Journal of Medicine today.

«Treatment with a shorter course of radiation and higher doses over fewer days may be the preferred approach in appropriately selected patients with localized prostate cancer, reducing treatment time and cost to the patient, and increasing patient convenience and access to treatment.»

The ASCO report recommends active surveillance for most patients with low - risk, localized prostate cancer, using regular monitoring with the prostate - specific antigen, or PSA, blood test, prostate biopsy and digital rectal exam.

If a patient is diagnosed with localized prostate cancer that is aggressive, treatment can be curative.

The research, led by Daniel Krauss, M.D., a radiation oncologist, Beaumont Hospital — Royal Oak, found an association between positive post-radiation therapy biopsy results and subsequent clinical outcomes in men with localized prostate cancer.

Independent target metabolite analyses revealed significant increases of sarcosine, glycine and choline tissue levels from benign prostate tissue to localized prostate cancer and subsequently metastatic disease.

Based on these studies, as well as others showing a potential synergistic effect of CTLA - 4 blockade with anti-androgen therapy, Dr. Sharma initiated a pre-surgical clinical trial of anti-CTLA-4 in patients with localized prostate cancer.

The rate of mutations in these genes was nearly 12 % among these men, compared to about 5 % among men with slower growing, localized prostate cancer.

Ablatherm - HIFU is generally recommended for patients with localized prostate cancer (stages T1 - T2) who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment, Ablatherm - HIFU is approved and commercialized in Europe as a treatment for prostate cancer and is currently under regulatory review in the U.S..

Long - Term Outcomes and Prognosis of Transrectal High - Intensity Focused Ultrasound Therapy for Patients with Localized Prostate Cancer — Therapy after Recurrence and Predictive Factors